|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-05
|
$593,588
|
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Wnt pathway dynamics in breast cancer metastasis
|
5K22CA207463-02
|
$188,042
|
|
ROARTY, KEVIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vitamin D and Follicular Lymphoma
|
5R01CA214890-02
|
$615,082
|
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
Virus-Targeted Therapy for Malignancies
|
1R43CA153474-01A1
|
$288,895
|
$144,448
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$2,429
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF signaling in Mammary Tumorigenesis
|
5R01CA168464-07
|
$397,813
|
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome
|
1R21CA225507-01
|
$280,976
|
|
PAULOVICH, AMANDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$750
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$1,399
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$45,557
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT M.D. Anderson Cancer Center Lymphoma SPORE
|
5P50CA136411-03
|
$475,000
|
$109,250
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using Big Data to Estimate the Effects of Complex Cost-Sharing Rules on Colorectal Cancer Screening and Patient Health
|
5R21CA219229-02
|
$205,694
|
|
WHALEY, CHRISTOPHER
|
RAND CORPORATION
|
|
Using a Narrative-Based Approach to Reducing Indoor Tanning
|
1R21CA226133-01
|
$173,456
|
|
PAGOTO, SHERRY
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-05
|
$351,104
|
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
|
1R01CA226861-01
|
$382,013
|
|
MACIAN, FERNANDO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Urban Revitalization and Long-Term Effects on Diet, Economic, and Health Outcomes
|
5R01CA149105-07
|
$566,078
|
|
DUBOWITZ, TAMARA
|
RAND CORPORATION
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-27
|
$2,137,632
|
$21,376
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)
|
5U01AI035041-26
|
$210,000
|
|
RINALDO, CHARLES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-24
|
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
5R01CA181633-05
|
$332,000
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding the mechanism of action for anticancer sulfonamides that target splicing
|
1R37CA226771-01
|
$366,647
|
|
NIJHAWAN, DEEPAK
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
|
1R01CA228589-01
|
$601,819
|
|
SETIAWAN, VERONICA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$218,895
|
$21,889
|
Fowler, Daniel
|
CCR (NCI)
|
|
Understanding succinate-induced global transcriptional and epigenetic reprogramming and identifying unique vulnerabilities intrinsic to SDH-deficient cells
|
5F30CA220660-02
|
$44,724
|
|
SMESTAD, JOHN
|
MAYO CLINIC ROCHESTER
|
|
Understanding mechanistic role of SAMHD1 in DNA damage response and therapeutic benefit for malignant glioma
|
1K01CA226346-01
|
$109,734
|
|
DADDACHA, WAAQO
|
EMORY UNIVERSITY
|
|
Understanding DNA break repair pathway choice regulation by the cNHEJ inhibitor CYREN
|
1R01CA227934-01
|
$440,115
|
|
KARLSEDER, JAN
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
|
5R01CA198089-04
|
$663,135
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
UNC Oncology Clinical/Translational Research Training Program (OCT-RTP)
|
2K12CA120780-11
|
$547,714
|
|
KIM, WILLIAM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Unbiased identification of spliceosome vulnerabilities across cancer
|
1R01CA226802-01
|
$455,925
|
|
SALOMONIS, NATHAN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
UM Calabresi Clinical Oncology Research Career Development Award
|
1K12CA226330-01
|
$54,000
|
|
SLINGERLAND, JOYCE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
UCSF-Gladstone Center for AIDS Research
|
5P30AI027763-27
|
$353,496
|
|
VOLBERDING, PAUL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UCLA Tumor Immunology Institutional Traning Grant
|
2T32CA009120-41A1
|
$497,990
|
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UAB Center for AIDS Research
|
5P30AI027767-30
|
$162,000
|
|
SAAG, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UAB Cancer Prevention and Control Training Program (T32)
|
2T32CA047888-29
|
$288,255
|
|
DEMARK-WAHNEFRIED, WENDY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-08
|
$325,684
|
$3,257
|
Kim, Edward
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tunable Microchip Sorting of BRCA1 Nuclear Assemblies
|
5R01CA193578-04
|
$363,836
|
|
KELLY, DEBORAH
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
5R01CA200574-03
|
$359,138
|
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$183,451
|
$73,380
|
Hakim, Frances
|
CCR (NCI)
|
|
Tumor vasculature-targeted nanotherapeutics for DNA damage response
|
5R01CA193880-03
|
$364,856
|
|
SHEN, HAIFA
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
|
1R01CA227433-01
|
$608,862
|
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions
|
5F30CA196087-03
|
$49,524
|
|
WATCHMAKER, JENNIFER
|
VANDERBILT UNIVERSITY
|
|
Trinity: Transcriptome assembly for genetic and functional analysis of cancer
|
2U24CA180922-06
|
$821,203
|
|
REGEV, AVIV
|
BROAD INSTITUTE, INC.
|
|
Treating prostate cancer by pharmacological coinhibition of the Warburg effect and lipogenesis
|
5R21CA205096-02
|
$164,756
|
|
FLAVENY, COLIN
|
SAINT LOUIS UNIVERSITY
|
|
Treating cognitive impairments in cancer patients via systematic light exposure
|
5K07CA184145-05
|
$166,167
|
|
WU, LISA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Hodgkins disease for this search: $14,783,055
|